Overview

This analysis examines technological advances in modular and automated platforms for non-biologics manufacturing in the pharmaceutical sector. There is a growing demand for automated and modular technologies that ensure regulatory compliance, increase productivity, reduce waste, and meet emerging therapeutic requirements such as those of the personalized medicine sector.

Advancements in technology are also influenced by the Pharma 4.0 megatrend, which entails higher usage of AI, IoT, and Big Data. These developments help improve efficiency and productivity, identify errors in manufacturing at an early stage, and maintain audit trails through digitization. They have reduced human intervention, brought flexibility, and made cleanups and changeovers easier.

• How can your company capitalize on modular and automated platforms to achieve significant growth in non-biologics manufacturing?
• How can your team leverage advancements in AI, IoT, and data analytics to drive transformation in pharmaceutical manufacturing?
• What best practices should be adopted to ensure regulatory compliance while implementing automated technologies that pave the way for growth?

Quick links

Click here to download the sample of this analysis

Already a member? Click here to access the analysis

Frost Honorarium Program

Unlock a $1,000 Incentive with a Complimentary Growth Dialog

Engage with our industry experts for a discussion to explore new growth opportunities for your business.

As a token of appreciation, you will receive a $1,000 honorarium—redeemable towards any of our products or services.

Schedule Your Growth Dialog Today!